Highlights from our AI in Private Healthcare: Driving Commercial, Operational and Clinical Excellence Report:

  • Currently valued at an estimated $26.7bn, LaingBuisson projects the global AI healthcare market could surge to $614bn by 2034 with a compound annual growth rate (CAGR) of 36.8%.
  • 60% of AI investment in healthcare is currently directed towards alleviating administrative burdens rather than direct patient care activities. This may reflect the lower regulatory and adoption hurdles in these areas.
  • Around the world, private and public sector partnerships with technology companies are delivering observable improvements today for providers and patients in clinical support, administration, maintenance and discharge procedures, monitoring and postoperative follow up.
  • This global outlook shows the US and China lead in AI adoption when assessed against key metrics such as total AI investment in 2023, the AI readiness index, the number of ongoing AI-focused clinical trials.

AI is an exciting area of growth for healthcare. Around the world, this technology is being hailed as a solution for multifaceted problems. Pain points to be solved include growing patient loads, increasingly complex patient cases, and a stressed workforce frustrated with administrative burdens.

The AI healthcare market is valued globally at $26.7bn today and is expected to surge to $614 by 2034. That growth depends on readiness at micro and macro levels. As such, this report considers the wider AI ecosystem, regulatory landscape and attitudes, which could explain the global variability we found in readiness for AI solutions.

This report, developed by LaingBuisson in partnership with sector experts Curzon Consulting, consolidates insights from over 60 hospitals across 26 countries, examining AI’s current and future applications in the healthcare sector. It provides a global overview of AI adoption, identifies key trends and challenges, and offers strategic recommendations to guide healthcare providers in maximising AI’s value.

While focused on elective care providers as primary stakeholders, the report also provides insights for a broader range of interested parties, including those working in other areas of healthcare delivery, investors and those working in support functions.

At a time when healthcare expenditure is climbing, using AI to improve offerings diffuses stress on currently overloaded points in the patient journey. The solutions explored in this report are far reaching, enabling efficiency savings and a redesigned service that truly puts the patient at the centre.

Chetan Trivedi, co-report author and Partner, Healthcare at Curzon Consulting, said:

“The integration of Artificial Intelligence (AI) in private healthcare offers transformative potential, especially in elective care. By automating critical processes, AI can greatly enhance operational efficiency, enabling healthcare providers to offer more precise and personalised care. The report sheds light on how AI-driven solutions are already reshaping the landscape, making healthcare delivery more sustainable and accessible while addressing the growing challenges of costs and workforce shortages.

“Our findings, based on insights from over 60 hospitals across 26 countries, underscore the global appetite for AI adoption in healthcare. AI’s role in diagnostics, treatment planning, and operational management promises significant improvements in patient outcomes, from faster diagnoses to more effective treatments. However, realising AI’s full potential depends on overcoming barriers such as data integration, workforce readiness, and regulatory compliance.

“AI is not just a tool for operational efficiency; it is set to enable us to transform and reinvent how we approach patient care. The future will see AI facilitating greater patient autonomy, supporting healthcare professionals in decision-making, and improving the overall patient experience. This report serves as a vital guide for healthcare leaders looking to navigate and capitalise on the opportunities that AI presents in delivering both clinical and commercial excellence.”

Tim Read, Director of Research and Content at LaingBuisson, said:

“Ever since it first emerged, the potential for AI to drive a radical reshaping of healthcare delivery has been clear. However, for a long time it seemed to remain as exactly this – potential. What our latest report makes clear is that these possibilities are now in the present. 

“Our latest report looks across the world and finds examples of AI being put into practical use by pioneering organisations on every continent. It is not just USA, China and Europe leading the way, but we see innovative uses for AI in Brazil, Turkey and India. 

“Over the next ten years, we expect AI solutions to become an integrated part of a successful healthcare provider – and as a result, we project the global AI healthcare market to grow by a staggering 36% annually to reach $614bn by 2034”